[Therapy-induced hepatitis risk in hemophilia patients].
D001782:Blood Donors; D001803:Blood Transfusion; D003428:Cross Infection / Q000209:etiology; D005164:Factor IX / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000628:therapy*; D006509:Hepatitis B / Q000209:etiology* / Q000517:prevention & control; D006526:Hepatitis C / Q000209:etiology* / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000209:etiology*; D006801:Humans; D012306:Risk
D005169:Factor VIII; D005164:Factor IX
Zum therapiebedingten Hepatitisrisiko der Hämophiliekranken.